ASPECT BIOSYSTEMS LTD.

Company Snapshot

Founded: 2013
Entity Type: Private
Region: Canada
Headquarter: British Columbia, Canada
Key Geographics: Canada
Corporate Address: 2131 Manitoba Street, Vancouver, British Columbia, V5Y 0N7 Canada Tel. +1-604-263-0502 www.aspectbiosystems.com

Company Overview

Aspect Biosystems Ltd., founded in 2013 as a spinoff from the University of British Columbia, is developing 3D bioprinting and tissue engineering platforms for producing living tissues for clinical and preclinical applications. The initial focus for the company is on printed tissue models for toxicity testing.

Aspect Biosystems’ Lab-on-a-Printer platform is a unique method for developing advanced 3D tissue models rapidly and for a wide range of cell types. The bioprinter printhead can align 24 or 48 wells, each of which contains different bioinks, and all operate in parallel. 

ASPECT BIOSYSTEMS LTD. In Reports

Bioprinting: Technologies and Global Markets

Global bioprinting technologies market should reach $5.0 billion by 2027 from $2.4 billion in 2022 at a CAGR of 16.2% for the forecast period of 2022-27.

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

BCC Research Market Report for Laboratory Animal Models, 3D Cultures and Organoids Market. Global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a CAGR of...

3D Printed Medical Devices

BCC Research Market Report for 3D printed medical devices should grow from $1.7 billion in 2021 to $4.9 billion by 2026, at compound annual growth rate (CAGR) of 24.5%

Company's Business Segments

  • Product : Bioprinting Technology, Tissue Therapeutic Platform
  • Services : Therapeutic Programs, Collaborative Partnerships

Applications/End User Industries

  • Biotechnology
  • Pharmaceuticals
  • Healthcare
AI Sentiment